NLRP3 and type 2 diabetes mellitus: It has also been shown that NLRP3 inflammasome, a master regulatory system of mature interleukin (IL)-1β secretion24, is highly activated in monocyte-derived macrophages from patients with T2DM, and that metformin treatment reduces the secretion of mature IL-1β25.